Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Orchestra BioMed Holdings, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 3 | -$0.50 | -$0.44 | -$0.48 |
| Q2 2025 | 1 | -$0.48 | -$0.48 | -$0.48 |
| Q3 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q4 2025 | 1 | -$0.52 | -$0.52 | -$0.52 |
| Q1 2026 | 1 | -$0.54 | -$0.54 | -$0.54 |
| Q2 2026 | 1 | -$0.46 | -$0.46 | -$0.46 |
| Q3 2026 | 1 | -$0.42 | -$0.42 | -$0.42 |
| Q4 2026 | 1 | -$0.41 | -$0.41 | -$0.41 |
| Q1 2027 | 1 | -$0.49 | -$0.49 | -$0.49 |
| Q2 2027 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q3 2027 | 1 | -$0.43 | -$0.43 | -$0.43 |
| Q4 2027 | 1 | -$0.44 | -$0.44 | -$0.44 |
| Q1 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2028 | 1 | $0.00 | $0.00 | $0.00 |
| Q1 2029 | 1 | $0.00 | $0.00 | $0.00 |
| Q2 2029 | 0 | $0.00 | $0.00 | $0.00 |
| Q3 2029 | 0 | $0.00 | $0.00 | $0.00 |
| Q4 2029 | 1 | $0.00 | $0.00 | $0.00 |
Orchestra BioMed Holdings, Inc. Earnings Date And Information
Orchestra BioMed Holdings, Inc. last posted its earnings results on Monday, March 31st, 2025. The company reported $-0.43 earnings per share for the quarter, missing analysts' consensus estimates of $-0.43 by $0. The company had revenue of 253,000 for the quarter and had revenue of 2.64 M for the year. Orchestra BioMed Holdings, Inc. has generated $0 earnings per share over the last year ($-0.0017 diluted earnings per share) and currently has a price-to-earnings ratio of -1.8. Orchestra BioMed Holdings, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based on prior year's report dates.
Orchestra BioMed Holdings, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/31/2025 | Q4 2024 | -$0.43 | -$0.44 | -0.01 | $838,667 | $253,000 |
| 11/12/2024 | Q3 2024 | -$0.44 | -$0.41 | 0.03 | $703,250 | $987,000 |
| 08/12/2024 | Q2 2024 | -$0.41 | -$0.45 | -0.04 | $850,000 | $778,000 |
| 05/13/2024 | Q1 2024 | -$0.40 | -$0.38 | 0.02 | $950,000 | $620,000 |
| 03/27/2024 | Q4 2023 | -$0.38 | -$0.36 | 0.02 | $994,500 | $262,000 |
| 09/29/2023 | Q3 2023 | N/A | -$0.38 | N/A | $895,000 | $419,000 |
| 06/30/2023 | Q2 2023 | N/A | -$0.35 | N/A | $706,000 | $915,000 |
| 03/31/2023 | Q1 2023 | N/A | -$0.40 | N/A | $680,000 | $1.16 M |
| 12/30/2022 | Q4 2022 | N/A | -$0.08 | N/A | $1.18 M | $1.10 M |
| 09/29/2022 | Q3 2022 | N/A | -$0.05 | N/A | N/A | $1.16 M |
| 06/30/2022 | Q2 2022 | N/A | -$0.25 | N/A | N/A | $401,000 |
| 03/31/2022 | Q1 2022 | N/A | -$0.18 | N/A | N/A | $866,000 |
| 12/30/2021 | Q4 2021 | N/A | -$0.00 | N/A | N/A | $-2,453,000 |
| 09/29/2021 | Q3 2021 | N/A | -$0.00 | N/A | N/A | $1.33 M |
| 06/29/2021 | Q2 2021 | N/A | -$0.00 | N/A | N/A | $-978,000 |
| 03/30/2021 | Q1 2021 | N/A | -$0.01 | N/A | N/A | $1.32 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Orchestra BioMed Holdings, Inc. Earnings: FAQ's
Orchestra BioMed Holdings, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, May 9th, 2025 based offlast year's report dates.
The conference call for Orchestra BioMed Holdings, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Orchestra BioMed Holdings, Inc.'s latest earnings report can be read online.
Orchestra BioMed Holdings, Inc. (:OBIO) has a recorded annual revenue of $2.64 M.
Orchestra BioMed Holdings, Inc. (:OBIO) has a recorded net income of $-61,024,000.Orchestra BioMed Holdings, Inc. has generated $-0.0017 earnings per share over the last four quarters.
Orchestra BioMed Holdings, Inc. (:OBIO) has a price-to-earnings ratio of -1.8 and price/earnings-to-growth ratio is 0.36.